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Abstract
Background: Existing literature on mood disorders suggests that the demographic distribution of bipolar disorder
may differ from that of unipolar depression, and also that bipolar disorder may be especially disruptive to personal
functioning. Yet, few studies have directly compared the populations with unipolar depressive and bipolar
disorders, whether in terms of demographic characteristics or personal limitations. Furthermore, studies have
generally examined work-related costs, without fully investigating the extensive personal limitations associated with
diagnoses of specific mood disorders. The purpose of the present study is to compare, at a national level, the
demographic characteristics, work productivity, and personal limitations among individuals diagnosed with bipolar
disorder versus those diagnosed with unipolar depressive disorders and no mood disorder.
Methods: The Medical Expenditure Panel Survey 2004-2006, a nationally representative survey of the civilian, non-
institutionalized U.S. population, was used to identify individuals diagnosed with bipolar disorder and unipolar
depressive disorders based on ICD-9 classifications. Outcomes of interest were indirect costs, including work
productivity and personal limitations.
Results: Compared to those with depression and no mood disorder, higher proportions of the population with
bipolar disorder were poor, living alone, and not married. Also, the bipolar disorder population had higher rates of
unemployment and social, cognitive, work, and household limitations than the depressed population. In
multivariate models, patients with bipolar disorder or depression were more likely to be unemployed, miss work,
and have social, cognitive, physical, and household limitations than those with no mood disorder. Notably, findings
indicated particularly high costs for bipolar disorder, even beyond depression, with especially large differences in
odds ratios for non-employment (4.6 for bipolar disorder versus 1.9 for depression, with differences varying by
gender), social limitations (5.17 versus 2.85), cognitive limitations (10.78 versus 3.97), and work limitations (6.71
versus 3.19).
Conclusion: The bipolar disorder population is distinctly more vulnerable than the population with depressive
disorder, with evidence of fewer personal resources, lower work productivity, and greater personal limitations. More
systematic analysis of the availability and quality of care for patients with bipolar disorder is encouraged to identify
effectively tailored treatment interventions and maximize cost containment.
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Mood disorders are among the most prevalent and costly
health problems in the U.S. These conditions–which
include unipolar (major depression, dysthymia, depres-
sion NOS) and bipolar disorders (bipolar types I and II,
bipolar NOS)–are not uncommon. In the U.S., the 12-
month prevalence rate for any mood disorder is approxi-
mately 9.5% [1]. Furthermore, mood disorders incur a
massive economic burden, including millions of dollars
in direct costs, such as health care expenditures [2-5].
Total costs reach into the billions after adding indirect
costs, such as diminished work productivity [6-10].
Mood disorders are neither identical nor uniformly
distributed, and differ in their respective impacts. Bipo-
lar disorder not only carries unique symptoms (e.g.,
mania/hypomania), but also is distinct from unipolar
depression in its prevalence and costs. For instance,
whereas the 12-month prevalence of major depression is
approximately 6.7% [1], it is between only 2% and 2.6%
for bipolar disorder I and II [1,11]. Also, there is some
evidence that the population distribution of bipolar dis-
order differs demographically (by age, sex, etc.) from the
populations with depression or with neither condition
[12,13]. In addition, despite lower prevalence, the total
economic costs are relatively higher for bipolar disorder
than for depression [14,15]. In fact, compared to several
other conditions, bipolar depression had the highest per-
centage of cost in relation to work absences or short
term disability [16].
The costs of mood disorders and other conditions are
not limited to health care or work productivity. For an
affected individual, the impact of mood disorders is dif-
fused throughout daily life via physical, cognitive, and
social limitations, such as poorer psychomotor control,
attention deficits, and disrupted social role functioning
[17-19]. Here again, bipolar disorder may incur particu-
larly high disablement due to greater numbers of
depressive episodes [20], higher functional impairment
[21], and more prominent cognitive impairment or psy-
choses [22,23]. Still, despite the potentially far-reaching
implications of these limitations for the individual and
society, they are more difficult to detect or quantify
than work absenteeism or financial costs. Consequently,
evidence regarding the individual (versus economic or
societal) costs of mood disorders–and especially how
these costs manifest among populations with bipolar
disorder versus depression and no mood disorder–is
extremely limited.
T h eu n i q u ep r e v a l e n c ea n dc o s t so fb i p o l a rd i s o r d e r
provide our point of departure. The U.S. population
with bipolar disorder is a potentially unique and vulner-
able group. Yet, despite a small amount of existing lit-
erature [21], the differences in prevalence and costs
between populations with unipolar depressive disorders
versus bipolar disorder remain unknown, hindering the
potential for effectively targeting these populations with
mental health programming and policy. Furthermore,
analyses at the level of individuals impacted by mood
disorders, especially concerning bipolar disorder, are lar-
gely absent. The goals of this study are 1) to assess the
demographics of mood disorder populations at a
national level, and 2) to measure the distinct societal
and individual costs for patients with bipolar disorder
versus patients those with depression or no mood
disorder.
Methods
This study was deemed exempt of Institutional Review
Board (IRB) approval by the Mayo Clinic Rochester IRB.
Data and study population
The Medical Expenditure Panel Survey (MEPS) 2004-
2006 Household and Medical Condition files were used
to identify individuals with mood disorders. The MEPS
is an ongoing study conducted by the Agency for
Healthcare Research and Quality (AHRQ) that began in
1996. A nationally representative survey of the U.S. civi-
lian, non-institutional population, the MEPS is designed
to collect information about health status, medical care
use, and expenditures, along with demographic and
socioeconomic characteristics of the population. It uti-
lizes an overlapping panel design in which individuals
are interviewed five times over a period of 30 months
[24]; from this, annualized estimates of population char-
acteristics, health, and health care can be produced [25].
Although the MEPS collects data about people of all
ages, the focus of the current study was limited to those
aged 18 to 64.
Measures
Diagnoses of unipolar depression and bipolar disorders
were based on the ICD-9 classification system. Detailed
ICD-9 codes were obtained at the National Center for
Health Statistics Research Data Center in Hyattsville,
MD. Diagnoses of 296.00-296.16 or 296.40-296.99 in
a n yw a v eo ft h eM E P Sp a n e lw e r ec l a s s i f i e da sb i p o l a r
disorder. Diagnoses of 296.20-296.36, 300.40 or 311
were classified as depression. Individuals with a diagno-
sis of bipolar disorder, with or without a diagnosis of
depression, were classified as bipolar disorder. Indivi-
duals with a diagnosis of depression and no diagnosis of
bipolar disorder were classified as depression. Remaining
individuals comprised the non-mood disorder popula-
tion, including all non-institutionalized U.S. adults with-
out diagnoses of bipolar disorder or depression. No
distinction was made within these three groups
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or other psychotic disorders.
The key outcomes of interest pertain to the indirect
costs of mood disorders, namely the lost work produc-
tivity and personal limitations associated with a diagno-
sis of bipolar disorder or a depressive disorder. Both
types of costs can be thought of as morbidity or produc-
tivity costs, i.e., the “lost or impaired ability to work or
engage in leisure time activities due to morbidity” [26].
Lost work productivity was the more conventional
among cost of illness studies [27,28], and pertained to
workforce participation and absenteeism. This was
assessed with three related items. The first concerned
whether individuals were employed (full- or part-time)
or were full-time students. The second, for individuals
who were employed, concerning whether an individual
had missed at least 10 days of work (i.e., two work
weeks) in a year due to illness. Third, to further assess
the extent of lost productivity, we also employed an
item regarding whether the individual had spent at least
10 days of missed work in bed. Personal limitations
were more unique among extant literature, and con-
cerned the impact of mood disorders on individual func-
tioning and self-sufficiency. This was measured via self
reports of: 1) physical limitations (defined as “difficulty
in walking, climbing stairs, grasping objects, reaching
overhead, lifting, bending or stooping, or standing for
long periods”); 2) social limitations (on “participation in
social, recreational, or family activities”); 3) cognitive
functioning (confusion, memory loss, or problems in
decision-making that interfered with daily activities); or
4) being “limited, in any way, in the ability to work at a
job, do housework, or go to school.” We recognize that
distinctions between productivity and personal limita-
tions are somewhat arbitrary, as personal functioning is
certain to affect one’s ability to work. The measures of
lost productivity and self-reported limitations, moreover,
are in some cases very similar. However, we do not
claim that these domains are unrelated; rather, we use
this approach in order to explore the pervasive disable-
ment among the populations with bipolar disorder and
depression.
Covariates of interest included gender; age; cate-
gories for race/ethnicity; marital status (married versus
not married); income; education; living arrangement
(living alone versus living with another adult and/or
child); an individual count of comorbid conditions (out
of 15 total conditions including myocardial infarct, car-
diovascular disease, dementia, ulcers, liver or kidney
disease, diabetes, AIDS, cancer, and others used in the
Charlson comorbidity index [29]); geography (living in
a metropolitan statistical area versus not); and region
(living in the Northeast, Midwest, South, or Western
U.S.).
Analytic Approach
Due to the relatively small sample of individuals with
bipolar disorder in MEPS, estimates from the 2004-2006
MEPS were combined, representing an annualized
three-year average over this time period. All analyses
employed survey weights to represent the U.S. adult,
non-institutionalized population. The weights also
accounted for panel attrition over the two years that
individuals were in the MEPS. Analyses were performed
using StataSE 10.0 in order to account for the complex
survey design of the MEPS. All reported differences are
significant at p < 0.05, unless otherwise noted.
We compared the population with bipolar disorder to
those with depression and with no mood disorder, with
respect to a) demographic composition, and b) work
and personal impact. T-tests for independent samples
served to detect significant differences between popula-
tions. To ensure that the findings from bivariate ana-
lyses were not driven by underlying demographic
patterns, we used logistic regression to isolate the inde-
pendent impacts of bipolar disorder and depression on
work productivity and personal limitations. Multivariate
analyses of work impact were also subdivided into full-
sample and gender sub-sample analyses due to the
potential for unemployment or missed work to be differ-
entially distributed along gender lines.
Results
Weighted estimates for the population indicated 1.65
million individuals with a diagnosis of bipolar disorder
(0.9% of the adult population), and 16.9 million indivi-
duals with depression (9.2% of the adult population; see
Table 1). Compared to the population with depressive
disorders, the population diagnosed with bipolar disor-
der was generally younger, not married, poorer (espe-
cially in the lowest income category), more commonly
living alone, and less educated (with a lower proportion
holding at least a college degree). Compared to the non-
mood disorder population, the bipolar disorder popula-
tion was generally female, non-Hispanic white or multi-
ple-race, not married, poorer (again concentrated in the
lowest income category), less educated (again, a lower
proportion holding at least a college degree), living
alone or living with only a child more prevalently (and
living with another adult, or an adult and a child, less
prevalently), and less often free of comorbid conditions.
A l s o ,t h eb i p o l a rd i s o r d e rp opulation tended to cluster
more in the central age range (35-44), giving it a nar-
rower age distribution than the non-mood disorder
population.
Work Productivity
A significantly lower proportion of the bipolar disorder
population was employed or enrolled as full-time
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mood disorder population, adults 18-64, United States, 2004-2006
Bipolar disorder Depression Non-mood disorder
(n = 572) (n = 5,464) (n = 53,905)
Total U.S. Population
(18-64)
1,647,408 16,874,994 165,702,423
0.9% 9.2% 90.0%
Gender
Male 35.2% 33.3% 51.1% *
Female 64.8% 66.7% 48.9% *
Age
18-24 11.4% 9.7% 16.1% *
25-34 20.7% 16.2% 22.0%
35-44 30.3% 23.0% * 23.1% *
45-54 25.1% 28.8% 22.3%
55-64 12.5% 22.3% * 16.6% *
Race/Ethnicity
Hispanic 8.1% 9.4% 14.8% *
NH White 74.3% 77.9% 65.8% *
NH Black 9.2% 7.8% 12.3%
NH Multiple 4.7% 2.4% 1.2% *
NH Other 3.8% 2.5% 6.0%
Marital status
Married 35.8% 48.1% * 56.3% *
Other 64.2% 51.9% * 43.8% *
Income (% Federal Poverty Level)
< 200% 39.0% 21.3% * 13.5% *
200-399% 39.3% 43.4% 43.4%
> = 400% 21.7% 35.4% * 43.1% *
Educational Attainment (24 and older)
Less than High School grad 16.6% 15.9% 14.3%
High School grad 35.7% 31.9% 30.9%
Some College 27.1% 24.7% 23.3%
College degree or more 20.7% 27.4% * 31.5% *
Living Arrangement
Living Alone 37.6% 25.6% * 17.1% *
Living with child and adult 24.5% 29.0% 40.3% *
Living with adult only 29.4% 38.2% * 38.4% *
Living with child only 8.5% 7.2% 4.2% *
Comorbid conditions
0 78.8% 74.9% 88.3% *
1 16.9% 19.5% 10.3% *
2 2.9% 4.6% 1.2%
3 or more 1.4% 1.1% 0.2%
Geography
Metropolitan Statistical Area (MSA) 19.9% 17.5% 16.1%
Non-MSA 80.1% 82.5% 83.9%
Region
Northeast 18.8% 16.6% 18.7%
Midwest 25.3% 25.6% 21.9%
South 32.1% 33.9% 36.3%
West 23.8% 23.9% 23.1%
* Indicates statistical difference (p < .05) between the bipolar disorder population versus the depression population or between the bipolar disorder population
versus the non-mood disorder population
Source: 2004-2006 MEPS
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order populations (42.8% compared to 63.3% and 80.7%,
respectively; see Table 2). Among those working, the
bipolar disorder group had a higher average number of
days missed, and a higher percentage of individuals who
missed at least two weeks of work (22.5% versus 6.3%),
than in the non-mood disorder population. Further-
more, a higher proportion of the bipolar disorder popu-
lation reported spending at least two weeks of missed
work in bed, compared to the depressed and non-mood
disorder populations (14.9% versus 8.2% and 2.9%,
respectively). In multivariate analyses for work/societal
limitations, we subdivided the living arrangement vari-
able into living with another adult, living with a child,
or living with both (with living alone as the reference
category)–rather than simply “living alone” versus “not
living alone"–to ensure that children or single parent-
hood were not disproportionately responsible for missed
work. Regardless, multivariate models (Table 3) echoed
bivariate findings: compared with the non-mood disor-
der population, individualsw i t hb i p o l a rd i s o r d e rh a d
about 4.6 times the odds of not working (95% CI 3.52,
6.04), 3.56 times the odds of missing at least two weeks
of work (95% CI 2.12, 6.04), and 4.6 times the odds of
spending at least 10 missed work days in bed (95% CI
2.75, 7.80). In similar fashion, individuals with depres-
sion also had higher odds of work-related costs than
those with no mood disorder, but their odds ratios
(between 1.93 and 2.37) were consistently smaller than
for individuals with bipolar disorder. Models separated
by gender suggested that the societal/work impacts of
both mood disorder categories were similar for men and
women; the point estimates were in most cases higher
for men, but the 95% confidence intervals for the gen-
ders (not shown) overlapped in all cases except depres-
sion’s effect on not working.
Personal Limitations
Compared to both depression and no mood disorder,
higher percentages of individuals diagnosed with bipolar
disorder reported social, cognitive, household, and work
functioning limitations (Table 4). Moreover, a greater
proportion of the bipolar disorder population also had
physical limitations than the non-mood disorder
Table 2 Self-reported societal limitations by individuals with bipolar disorder or depression compared to the non-
mood disorder population, adults 18-64, United States, 2004-2006
Bipolar disorder Depression Non-mood disorder
Employed/student status
Not working or not a student (if 18-23) 57.20% 36.70% * 19.30% *
Working or a student (if 18-23) 42.80% 63.30% 80.70% *
Missed days of work
Average 8.36 7.45 3.45 *
Missed 2 weeks (10 days) or more of work
No, missed fewer 77.50% 85.20% 93.70% *
Yes, missed 2 weeks or more 22.50% 14.80% 6.30% *
Missed days of work/spent in bed
Average 4.95 3.81 1.6 *
Missed work and in bed 2 weeks (10 days) or more
No, missed fewer 85.10% 91.90% * 97.10% *
Yes, missed 2 weeks or more 14.90% 8.20% * 2.90% *
* Indicates statistical difference (p < .05) between the bipolar disorder population versus the depression population or between the bipolar disorder population
versus the non-mood disorder population
Source: 2004-2006 MEPS
Table 3 Odds of self-reported societal limitations by
mood disorder, from multivariate analyses
Overall Women Men
Model outcome OR p-value OR p-value OR p-value
(SE) (SE) (SE)
Not working or not a student (if 18-23)
Bipolar disorder 4.61 < 0.001 3.99 < 0.001 7.48 < 0.001
(0.63) (0.62) (1.71)
Depression 1.93 < 0.001 1.72 < 0.001 2.65 < 0.001
(0.10) (0.11) (0.23)
Missed 2 weeks (10 days) or more of work
Bipolar disorder 3.56 < 0.001 3.64 < 0.001 3.57 0.003
(0.95) (1.19) (1.51)
Depression 2.11 < 0.001 1.96 < 0.001 2.61 < 0.001
(0.14) (0.15) (0.33)
Missed work and in bed 2 weeks (10 days) or more
Bipolar disorder 4.63 < 0.001 4.30 < 0.001 5.76 0.001
(1.23) (1.30) (3.09)
Depression 2.37 < 0.001 2.30 < 0.001 2.59 < 0.001
(0.22) (0.23) (0.47)
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work was reported by 40% of individuals with bipolar
disorder–a rate nearly 10 times that of the non-mood
disorder population and double that of the depression
population. In multivariate analyses (Table 5), bipolar
disorder and depression were significant, positive predic-
tors of each limitation, but odds ratios indicated more
prominent disablement for bipolar disorder. While
depression and bipolar disorder both had between 2.4
and 2.7 times the odds of physical limitations compared
to no mood disorder, the differences were more notable
among other limitations. For instance, depressed indivi-
duals had 2.9 times the odds of social limitations, rela-
tive to no mood disorder, but the odds ratio for bipolar
disorder was 5.1. Cognitive limitations were especially
striking: depression was associated with 3.9 times the
odds of cognitive limitations–but bipolar disorder was
associated with 10.8 times the odds of having cognitive
limitations, relative to no mood disorder. Continuing
this pattern, depression and bipolar disorder were
associated with, respectively, 3.2 and 6.7 times the odds
of work limitations, relative to no mood disorder.
Finally, depression meant 2.7 times the odds of house-
hold limitations, whereas bipolar disorder meant 3.5
times the odds, relative to no mood disorder.
Discussion
Mood disorders carry large indirect costs in terms of
lost productivity and personal burden. However, impor-
tant differences exist between the populations identified
as having bipolar disorder versus unipolar depression, in
regards to demographics, work, and individual function-
ing. This translates into the bipolar disorder population
having fewer resources, yet also greater disablement–i.e.,
it is a distinct, and particularly vulnerable, group.
In our analyses, the bipolar disorder population
tended to be younger, poorer, less educated, and more
often unmarried and living alone, than the population
with unipolar depression (not to mention differences
from the non-mood disorder population). These demo-
graphic differences suggest that those in the bipolar dis-
order population tend to have fewer resources and a
more limited social safety net than the depression popu-
lation. This has two implications. First, bipolar disorder
does not merely represent a unique subset of affective
and psychomotor symptoms [17,23]; rather, it also char-
acterizes a population which is demographically different
from the populations with depression and no mood
disorder.
A second implication is that, due to the relative disad-
vantages among the bipolar disorder population vis-à-vis
demographics and circumstances, individuals with bipo-
lar disorder may often be particularly susceptible to the
disruptive effects of mood disorders. This is especially
problematic when one considers our findings regarding
the high costs imposed by bipolar disorder. Namely, the
bipolar disorder population had higher rates of non-
employment, spending missed work days in bed, and
limitations in social, cognitive, work, and household
domains than in the depressed or non-mood disorder
populations. Moreover, multivariate analyses revealed
Table 4 Self-reported individual limitations by individuals with bipolar disorder or depression compared to the non-
mood disorder population, adults 18-64, United States, 2004-2006
Limitation Bipolar disorder Depression Non-mood disorder
Physical Limitation 27.40% 22.80% 6.40% *
Social Limitation 26.20% 14.00% * 2.80% *
Cognitive Limitation 31.20% 12.40% * 1.90% *
Work Limitation 39.20% 21.00% * 4.60% *
Household Limitation 21.20% 14.30% * 2.90% *
Any Limitation (work, household, school) 40.80% 22.00% 4.80%
* Indicates statistical difference (p < .05) between the bipolar disorder population versus the depression population or between the bipolar disorder population
versus the non-mood disorder population
Source: 2004-2006 MEPS
Table 5 Odds of self-reported individual limitations by
mood disorder
Model Outcome OR SE p-value
Physical
Bipolar disorder 2.68 0.38 < 0.001
Depression 2.46 0.14 < 0.001
Social
Bipolar disorder 5.17 0.78 < 0.001
Depression 2.85 0.20 < 0.001
Cognitive
Bipolar disorder 10.78 1.82 < 0.001
Depression 3.97 0.30 < 0.001
Work
Bipolar disorder 6.71 0.92 < 0.001
Depression 3.19 0.20 < 0.001
Household
Bipolar disorder 3.47 0.65 < 0.001
Depression 2.71 0.19 < 0.001
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sus depression) in not being employed and in having
social, cognitive, and work limitations. Our multivari-
ate gender subgroup analysis indicated that neither
gender is particularly safe from, or susceptible to, work
limitations, even controlling for varying living situa-
tions, suggesting that mood disorders’ impact on lost
productivity endures across demographic and personal
circumstances.
In sum, the bipolar disorder population is distinct
from the depressed and non-mood disorder populations
in its demographic characteristics and in the work costs
and personal limitations it incurs. Individuals diagnosed
with bipolar disorder face greater disablement, yet also
have fewer social and financial resources to call upon in
combating these limitations. Without specifically tai-
lored intervention, the special vulnerability of this popu-
lation may remain under-addressed, perpetuating the
disproportionately high work costs and personal burden
of bipolar disorder.
Limitations
The present study has several limitations. First, approxi-
mately 38% of the bipolar disorder population also had
a diagnosis of depression. No sensitivity analysis was
performed to either exclude these individuals or cate-
gorize them within the depression population. We can-
not say what kind of impact, if any, these individuals
had on study results. Second, we do not know if the
individuals in either mood disorder population were on
any disability program. It is possible that those on dis-
ability programs would be more likely to report poor
functioning if individuals believed that reporting good
functioning could endanger disability benefits. Third,
our outcome variables were based on self-reported
responses of the individuals surveyed, rather than work/
school records, more objective assessments of function-
ing, etc. No attempt is made in the MEPS to verify the
responses for these items. Fourth, diagnoses of bipolar
disorder and depression were based on individual
responses and confirmed by administrative data, but
were not confirmed by specific screening instruments or
exams. As such, patients may be incorrectly categorized.
Fifth, we do not include measurements of substance
abuse disorders/alcoholism or other psychiatric disor-
ders (e.g., schizophrenia) among our mood disorder or
non-mood disorder populations. This limits our ability
to further control or analyze the relationships between
mood disorders and disablement. For instance, we do
not examine whether alcohol plays a role in linking
mood disorders to lost work or cognitive limitations;
also, the non-mood disorder group could still have psy-
chiatric visits for other issues. Finally, although we con-
trolled for medical comorbidities, we did not explore
them in detail in order to fully assess their impact on
the relationship between mood disorders and work or
personal costs.
Conclusion
Individuals with mood disorders exhibited higher work
costs and personal limitations than non-mood disorder
population, and evidence indicated a particularly trou-
bling combination of potentially lower resources and
higher disablement associated with bipolar disorder.
Addressing the particular vulnerability of patients with
bipolar disorder is a necessity. Further empirical study
and policy attention to the quality and availability of
care for these patients may have a large societal payoff,
by identifying effective interventions and strategies for
containing the unique costs of bipolar disorder. For
instance, it is vital that programs be designed to target
the prominent personal limitations (especially cognitive
and social) experienced by individuals with bipolar dis-
order. It is likely these limitations are partially responsi-
ble for the greater productivity costs found. By
considering the broader impact of bipolar disorder in
individuals’ lives, a strong case is made to allocate
resources toward the management of this disorder’s
extensive reach.
In addition, bipolar disorder carries high productivity
costs, including unemployment and spending missed
work time in bed. The patterns found here in the differ-
ent measures for lost productivity suggest that measur-
ing lost work time among only employed individuals is
insufficient in detailing even the work costs of mood
disorders. It is vital that studies include non-employed
and non-student individuals in analyses, and also that
they examine the fullest extent of lost productivity (i.e.,
what happens during missed work time–full incapacita-
tion in bed or otherwise). It is possible that non-
employment itself, stemming from cognitive, social, or
other limitations, is the most excessive and least neces-
sary economic cost of mood disorders. Furthermore, it
is probable that spending time in bed (or in similar
states of disengagement) during missed work may be
especially detrimental to other health conditions, and
may stimulate further negative mood, similar to rumina-
tion in unipolar depression or anxiety [30].
Finally, if our results indicate anything, it is that bipo-
lar disorder represents not only a unique condition–one
that is distinct from unipolar depression–but also a
unique (and vulnerable) population. As such, relying on
an umbrella category of “mood/affective disorders” may
mask the differences between bipolar disorder and
depression, and between the respective demographic
groups who endure them. In turn, this lack of differen-
tiation may obstruct effective policy or treatment. Tai-
loring policy decisions with consideration for the
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thus vital in optimizing effectiveness and attacking
unnecessary costs. Successfully targeted mental health
policy requires differentiation within mood disorders to
account for the greater costs and vulnerability among
the bipolar disorder population.
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